Taiwan · Delayed Price · Currency is TWD Pharmigene Company Description
Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally.
It offers contract development and manufacturing organization; molecular diagnostic reagents; testing products, including pharmacogenomics, targeted therapy for cancer, disease risk assessment, and functional medicine services.
In addition, it sells various platform, such as single-cell analysis platform / spatial gene expression; single-cell and spatial transcriptomics data analysis software; expert in mapping genomic structural variations; whole-genome precision annotation platform; single-cell and spatial transcriptomics data analysis software; precise immune cell identification; automated tissue dissociator; and clinical HLA testing platform.
The company was founded in 1994 and is headquartered in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 1994 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Yingzhou Xu |
Contact Details
Address: No. 17, Lane 171, Section 2, Jiuzong Road Taipei Taiwan | |
| Phone | 886 2 2798 5885 |
| Website | pharmigene.com.tw |
Stock Details
| Ticker Symbol | 7595 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0007595B13 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Fuhui Zhan | Chairman, GM and Chief Executive Officer |
| Guanzhi Chen | Chief Operating Officer and Director |
| Dr. Yuan-Tsong Chen M.D., Ph.D. | Founder |
| Jie Rou Cai | Accounting Supervisor |